Ledger.Open graph →
SEC Form D · Amendment · filed April 12, 2016

Renibus Therapeutics, Inc

Offering
$12.5M
Sold
$10.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LANTANA, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Carlos Guillem · Lantana, TXExec · DirectorDale Jones · Lantana, TXDirectorNels D. Bergmark · Lantana, TXExecJocelyn D. Keyser · Lantana, TXDirectorJennifer D. Rasmussen · Lantana, TXDirectorHarpreet Kaur · Lantana, TXExec · DirectorLarry L. Adloff · Troy, MIExec · DirectorAlexander Bullington · Forest Hill, MDDirectorTimothy L. Hoel · Troy, MIDirectorArthur B. Mcwood · Troy, MIDirectorGregory Dinardo · Austin, TXExecJason L. Yoffy · Troy, MIExec · DirectorJohn B. Coppolino · Troy, MIExecLawrence B. Carlson · Troy, MIDirectorDaniel J. Jenuwine · Troy, MIExec · DirectorJim M. Hodge · Henderson, NVExec · DirectorRandon M. Hansen · Henderson, NVDirectorMark M. Stoker · Henderson, NVDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗